发明名称 Compounds for proteasome enzyme inhibition
摘要 Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
申请公布号 EP2270026(A2) 申请公布日期 2011.01.05
申请号 EP20100012497 申请日期 2005.08.08
申请人 ONYX THERAPEUTICS, INC. 发明人 SMYTH, MARK S.;LAIDIG, GUY J.
分类号 C07K5/103;A61K38/00;A61K38/04;A61K38/06;C07K5/04;C07K5/08;C07K5/087 主分类号 C07K5/103
代理机构 代理人
主权项
地址